A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
Open Access
- 8 July 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Medicine
- Vol. 6 (1), 19
- https://doi.org/10.1186/1741-7015-6-19
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Long-Term Prediction of Prostate Cancer Up to 25 Years Before Diagnosis of Prostate Cancer Using Prostate Kallikreins Measured at Age 44 to 50 YearsJournal of Clinical Oncology, 2007
- Decision Curve Analysis: A Novel Method for Evaluating Prediction ModelsMedical Decision Making, 2006
- Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at −20 °CClinical Chemistry, 2006
- Proenzyme Forms of Prostate-Specific Antigen in Serum Improve the Detection of Prostate CancerClinical Chemistry, 2004
- An Extended 10-Core Transrectal Ultrasonography Guided Prostate Biopsy Protocol Improves the Detection of Prostate CancerEuropean Urology, 2004
- Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA)Prostate Cancer and Prostatic Diseases, 2004
- Discrimination of Benign From Malignant Prostatic Disease by Selective Measurements of Single Chain, Intact Free Prostate Specific AntigenJournal of Urology, 2002
- Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocolBJU International, 2002
- Improving prostate cancer detection with an extended‐core transrectal ultrasonography‐guided prostate biopsy protocolBJU International, 2002
- Outcome of Laterally Directed Sextant Biopsies of the Prostate in Screened Males Aged 50–66 YearsEuropean Urology, 2001